EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

HPV-Independent Cervical Cancer—A New Challenge of Modern Oncology

Ruxandra Maria Hurjui, Ion Andrei Hurjui, Tudor Andrei Buțureanu iD, Diana Popovici iD, Elena-Roxana Avădănei, Raluca Anca Balan iD

International Journal of Molecular Sciences · 15.10.2025 · 26 (20) · 10051

DOI: 10.3390/ijms262010051 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.10.2025. Verfasst von Ruxandra Maria Hurjui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Morpho-Functional Sciences I, Grigore T. Popa University of Medicine and Pharmacy Iasi, 16 Universitatii Street, 700115 Iasi, Romania. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Papillomaviridae. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer is a major global health concern with serious implications for women’s health. It is most often caused by persistent infection with high-risk human papillomavirus (HPV) types. However, about 5–11% of cervical carcinoma cases are HPV-independent, entities with their own unique set of histopathological, molecular, and clinical features. The histopathological forms of HPV-independent cervical cancer include gastric-type adenocarcinoma, clear-cell, mesonephric, and endometrioid carcinoma. Unlike HPV-associated cervical cancers, which require E6 and E7 oncogenes for their expression, HPV-independent tumors exhibit specific mutations such as TP53, PIK3CA, KRAS, STK11, and PTEN. These mutations lead to alternative oncogenic pathways. Diagnosis of HPV-independent cervical adenocarcinoma is often delayed because of possible misclassification as endometrial adenocarcinomas, which frequently results from inadequate HPV testing. This often leads to advanced presentation stages, higher rates of lymphovascular invasion, and, in many cases, a reduced response to chemotherapy and immunotherapy—though outcomes can vary across histotypes and selected patient subgroups—due to the immune-cold tumor microenvironment. Although these morphologic and molecular characteristics describe tumors that are very difficult to manage, PI3K/mTOR and KRAS inhibitors may offer potential therapeutic options for selected patients. This review focuses on the pathogenic and molecular mechanisms, histopathological features, prognosis, and therapeutic difficulties of HPV-independent cervical cancers. Moreover, it provides a comprehension of contemporary issues in diagnostic methods and some new therapeutic approaches, suggesting the need for precision medicine in this aggressive type of cervical cancer. Further studies are necessary to enhance early detection, improve treatment results, and increase survival rates for patients with HPV-independent cervical cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsPapillomaviridaeHumansFemaleMutation

Stichwörter der Autor:innen

HPV-associated cervical adenocarcinomaHPV-associated cervical squamous carcinomaHPV-independent cervical adenocarcinomaHPV-independent cervical squamous carcinomamolecular classification of cervical cancer

Autor:innen und Institutionen

  • Department of Morpho-Functional Sciences I, Grigore T. Popa University of Medicine and Pharmacy Iasi, 16 Universitatii Street, 700115 Iasi, Romania.
  • Department of Medicine III, Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania.
  • Department Mother and Child Medicine, Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania.
  • "Elena Doamna" Clinical Hospital of Obstetrics and Gynecology, 49 Elena Doamna Street, 700398 Iasi, Romania.

ORCID-Profile: Tudor Andrei Buțureanu, Diana Popovici, Raluca Anca Balan

Zitieren

APA

Hurjui, R. M., Hurjui, I. A., Buțureanu, T. A., Popovici, D., Avădănei, E. R., & Balan, R. A. (2025). HPV-Independent Cervical Cancer—A New Challenge of Modern Oncology. International Journal of Molecular Sciences, 26(20), 10051. https://doi.org/10.3390/ijms262010051

Vancouver

Hurjui RM, Hurjui IA, Buțureanu TA, Popovici D, Avădănei ER, Balan RA. HPV-Independent Cervical Cancer—A New Challenge of Modern Oncology. International Journal of Molecular Sciences. 2025;26(20):10051. doi:10.3390/ijms262010051

BibTeX
@article{Hurjui2025,
  author = {Hurjui, Ruxandra Maria and Hurjui, Ion Andrei and Buțureanu, Tudor Andrei and Popovici, Diana and Avădănei, Elena-Roxana and Balan, Raluca Anca},
  title = {HPV-Independent Cervical Cancer—A New Challenge of Modern Oncology},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {20},
  pages = {10051},
  doi = {10.3390/ijms262010051}
}
Kostenlos starten →